glp-1 review Frontiers The expanding role of GLP-1
Description
Int J Chron Obstruct Pulmon Dis
Obesity and hypertension represent convergent public health challenges, as both contribute substantially to preventable cardiovascular disease and premature mortality
Cell Tissue Res
At this point, there is no completed clinical evidence showing that ultra-low GLP-1 dosing prevents Alzheimers disease
[DOI] [PMC free article] [PubMed] [Google Scholar] 9.Berenbaum F
Salas-Whalens clinical stance is clear: these drugs should be considered first-line therapy for the disease of obesity, not a last resort after years of failed diets
